News & Events about Opko Health Inc.
Globe Newswire
3 months ago
MIAMI, March 09, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that it will hold an R&D Day event on March 20, 2023 beginning at 4:00 p.m. Eastern time. The two-hour virtual event will provide an opportunity to hear from OPKO executives about the ModeX Therapeutics ...
Globe Newswire
3 months ago
MDX-2201 leverages ModeXs innovative biologics platform to target multiple Epstein-Barr virus (EBV) proteinsEBV is the leading cause of infectious mononucleosis and is also associated with some specific types of cancer MIAMI, March 08, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today ...
Globe Newswire
3 months ago
MIAMI, Feb. 16, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2022 after the close of the U.S. financial markets on Thursday, February 23, 2023. OPKOs senior management will provide a business update ...
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings PR Newswire ELMWOOD PARK, N.J., Feb. 9, 2023 CINtecPLUS Cytology offered as a reflex...
OPKO Health, Inc. (NASDAQ:OPK Get Rating) major shareholder Opko Health, Inc. purchased 14,285,714 shares of the stock in a transaction that occurred on Thursday, January 26th. The shares were bought at an average cost of $0.35 per share, for a total transaction of $4,999,999.90. Following the ...